Stryker Corporation $SYK Shares Acquired by Wedbush Securities Inc.

Wedbush Securities Inc. lifted its holdings in shares of Stryker Corporation (NYSE:SYK) by 11.5% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,720 shares of the medical technology company’s stock after purchasing an additional 799 shares during the period. Wedbush Securities Inc.’s holdings in Stryker were worth $3,054,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently bought and sold shares of SYK. Mid American Wealth Advisory Group Inc. acquired a new position in shares of Stryker in the second quarter worth $26,000. Sachetta LLC increased its position in Stryker by 58.7% during the 2nd quarter. Sachetta LLC now owns 73 shares of the medical technology company’s stock worth $29,000 after purchasing an additional 27 shares in the last quarter. Ridgewood Investments LLC raised its stake in Stryker by 48.4% in the 2nd quarter. Ridgewood Investments LLC now owns 92 shares of the medical technology company’s stock valued at $36,000 after purchasing an additional 30 shares during the last quarter. Ransom Advisory Ltd purchased a new position in Stryker in the 1st quarter valued at about $37,000. Finally, Solstein Capital LLC purchased a new position in Stryker in the 2nd quarter valued at about $43,000. Hedge funds and other institutional investors own 77.09% of the company’s stock.

Analyst Ratings Changes

SYK has been the subject of a number of analyst reports. BTIG Research boosted their price objective on shares of Stryker from $408.00 to $410.00 and gave the company a “buy” rating in a research report on Friday, October 31st. Wall Street Zen raised Stryker from a “hold” rating to a “buy” rating in a research note on Saturday, October 18th. Barclays raised their price objective on Stryker from $443.00 to $453.00 and gave the stock an “overweight” rating in a report on Wednesday, October 22nd. Needham & Company LLC upped their target price on Stryker from $442.00 to $448.00 and gave the company a “buy” rating in a research note on Friday, August 1st. Finally, Truist Financial reissued a “hold” rating and issued a $392.00 price target (down from $407.00) on shares of Stryker in a research note on Monday, November 3rd. Fourteen investment analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $433.37.

Insider Activity at Stryker

In other news, insider Viju Menon sold 500 shares of the stock in a transaction on Monday, August 25th. The shares were sold at an average price of $390.61, for a total value of $195,305.00. Following the completion of the sale, the insider owned 12,511 shares of the company’s stock, valued at $4,886,921.71. This represents a 3.84% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Ronda E. Stryker sold 276,173 shares of the firm’s stock in a transaction on Thursday, November 6th. The shares were sold at an average price of $353.28, for a total transaction of $97,566,397.44. Following the completion of the transaction, the director directly owned 2,702,108 shares in the company, valued at approximately $954,600,714.24. This represents a 9.27% decrease in their position. The SEC filing for this sale provides additional information. Over the last quarter, insiders have sold 520,500 shares of company stock valued at $184,803,065. 5.90% of the stock is owned by insiders.

Stryker Price Performance

SYK stock opened at $355.74 on Friday. The company has a market cap of $136.04 billion, a PE ratio of 47.12, a price-to-earnings-growth ratio of 2.66 and a beta of 0.94. The company has a current ratio of 1.78, a quick ratio of 1.06 and a debt-to-equity ratio of 0.70. The stock has a 50-day moving average price of $374.63 and a two-hundred day moving average price of $380.99. Stryker Corporation has a 12-month low of $329.16 and a 12-month high of $406.19.

Stryker (NYSE:SYK) last released its quarterly earnings data on Thursday, October 30th. The medical technology company reported $3.19 earnings per share for the quarter, beating the consensus estimate of $3.13 by $0.06. Stryker had a return on equity of 23.94% and a net margin of 12.25%.The business had revenue of $6.06 billion for the quarter, compared to analyst estimates of $6.04 billion. During the same period in the previous year, the company posted $2.87 EPS. The company’s revenue was up 10.2% compared to the same quarter last year. Stryker has set its FY 2025 guidance at 13.500-13.600 EPS. As a group, research analysts predict that Stryker Corporation will post 13.47 EPS for the current year.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.